Related references
Note: Only part of the references are listed.Pertactin-Negative Variants of Bordetella pertussis in the United States
Anne Marie Queenan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Priming with Whole-Cell versus Acellular Pertussis Vaccine
Juventila Liko et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Pregnancy Dose Tdap and Postpartum Cocooning to Prevent Infant Pertussis: A Decision Analysis
Andrew Terranella et al.
PEDIATRICS (2013)
Early Impact of the US Tdap Vaccination Program on Pertussis Trends
Tami H. Skoff et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2012)
Appearance of Bordetella pertussis Strains Not Expressing the Vaccine Antigen Pertactin in Finland
Alex-Mikael Barkoff et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Incomplete Financial Disclosure in a Viewpoint on Complementary and Alternative Therapies
Paul A. Offit
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Association of Childhood Pertussis With Receipt of 5 Doses of Pertussis Vaccine by Time Since Last Vaccine Dose, California, 2010
Lara K. Misegades et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
California Pertussis Epidemic, 2010
Kathleen Winter et al.
JOURNAL OF PEDIATRICS (2012)
Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children
Nicola P. Klein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Pertussis control: time for something new?
Thomas A. Clark et al.
TRENDS IN MICROBIOLOGY (2012)
Population Diversity among Bordetella pertussis Isolates, United States, 1935-2009
Amber J. Schmidtke et al.
EMERGING INFECTIOUS DISEASES (2012)
Acellular Pertussis Vaccine at Birth and One Month Induces Antibody Responses By Two Months of Age
Nicholas Wood et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Pertussis hospitalizations among infants in the United States, 1993 to 2004
Margaret M. Cortese et al.
PEDIATRICS (2008)
Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001
KM Bisgard et al.
PEDIATRICS (2005)
Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine
S Lugauer et al.
EUROPEAN JOURNAL OF PEDIATRICS (2002)
Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: The Italian experience
S Salmaso et al.
PEDIATRICS (2001)
Share Paper
